Antihypertensive Drugs Market by Type and Geography - Forecast and Analysis 2022-2026

Published: Sep 2022

Pages: 134

SKU: IRTNTR74202

Snapshot

The antihypertensive drugs market share is expected to increase by USD 5.87 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 3.1%.

This antihypertensive drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers antihypertensive drugs market segmentations by type (systemic hypertension and pulmonary hypertension) and geography (North America, Europe, Asia, and Rest of World (ROW)). The antihypertensive drugs market report also offers information on several market vendors, including Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Co Inc, Bayer AG, Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Lupin Ltd, Merck and Co. Inc., Noden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc., and Zydus Lifesciences Ltd. among others.

What will the Antihypertensive Drugs Market Size be During the Forecast Period?

Download Report Sample to Unlock the Antihypertensive Drugs Market Size for the Forecast Period and Other Important Statistics

Antihypertensive Drugs Market: Key Drivers, Trends, and Challenges

The availability of a wide range of drugs is notably driving the antihypertensive drugs market growth, although factors such as the advent of wearable defibrillators may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the antihypertensive drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Antihypertensive Drugs Market Driver

The availability of a wide range of drugs is one of the factors driving the antihypertensive drugs market growth. Patients with hypertension are generally treated with drugs that can reduce blood volume, systemic vascular resistance, and cardiac output by depressing heart rate and stroke volume. For example, diuretic drugs decrease blood volume by increasing urine output by the kidney. Similarly, vasodilator drugs dilate blood vessels through the relaxation of smooth muscle in blood vessels. Hence, the availability of a wide range of therapeutics is offering specific treatment to patients with hypertension and driving the growth of the market during the forecast period.

Key Antihypertensive Drugs Market Trend

The development of modified release formulations is one of the key antihypertensive drugs market trends fueling the market growth. Modified-release formulations are designed to delay the release of drugs in the body after their administration. Some of the modified-release formulations consist of sustained-release and controlled-release formulations. Sustained-release formulations maintain drug release over a sustained period but not at a constant rate, whereas controlled-release formulations maintain drug release over a sustained period at a nearly constant rate. Hence, pharmaceutical companies are developing these formulations for the treatment of hypertension. Thus, the modified-release formulations are expected to enter the market during the forecast period and add significant value to its growth.

Key Antihypertensive Drugs Market Challenge

The advent of wearable defibrillators is one of the factors impeding the antihypertensive drugs market growth. The global antihypertensive drugs market is witnessing increasing R&D efforts for the development of wearable cardiovascular defibrillators for the management of cardiovascular symptoms. Furthermore, studies revealed that the risk of stroke was reduced to half in patients who received the previous generation HeartMate II pump, which required an abdominal location for the implant. Thus, the high success rates associated with these devices have led to their increased adoption rate among end-users and limited the use of antihypertensive drugs to a certain extent among patients, thereby restricting market growth.

This antihypertensive drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global antihypertensive drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the antihypertensive drugs market during the forecast period.

Who are the Major Antihypertensive Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

This statistical study of the antihypertensive drugs market encompasses successful business strategies deployed by the key vendors. The antihypertensive drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

novartis.com - The company offers antihypertensive drugs such as Entresto.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The antihypertensive drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Antihypertensive Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the antihypertensive drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Antihypertensive Drugs Market?

For more insights on the market share of various regions Request PDF Sample now!

41% of the market’s growth will originate from North America during the forecast period. The US is the key market for the antihypertensive drugs market in North America. Market growth in this region will be slower than the growth of the market in Asia.

Rising awareness among people about hypertension will facilitate the antihypertensive drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 negatively affected regional market growth. However, by the second half of 2020, lockdown-related restrictions were somewhat relaxed in various countries, which allowed the movement of people outside their homes. Thus, the regional market will register growth during the forecast period.

What are the Revenue-generating Type Segments in the Antihypertensive Drugs Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The antihypertensive drugs market share growth by the systemic hypertension segment will be significant during the forecast period. The direct arterial dilator and direct venous dilator are also used for the treatment of patients with systemic hypertension. Moreover, centrally acting drugs that include clonidine, guanabenz, guanfacine, and Alpha-methyldopa are used to decrease sympathetic autonomic outflow for the reduction of systemic vascular resistance and cardiac output in patients with hypertension. All these specific treatments are expected to treat patients with systemic hypertension and drive the growth of the segment.

This report provides an accurate prediction of the contribution of all the segments to the growth of the antihypertensive drugs market size and actionable market insights on post COVID-19 impact on each segment.

Antihypertensive Drugs Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 3.1%
Market growth 2022-2026	$ 5.87 billion
Market structure	Fragmented
YoY growth (%)	2.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 41%
Key consumer countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Co Inc, Bayer AG, Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Lupin Ltd, Merck and Co. Inc., Noden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc., and Zydus Lifesciences Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Antihypertensive Drugs Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive antihypertensive drugs market growth during the next five years
Precise estimation of the antihypertensive drugs market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the antihypertensive drugs industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of antihypertensive drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)

5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type

5.3 Systemic hypertension - Market size and forecast 2021-2026
- Exhibit 28: Chart on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Systemic hypertension - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Systemic hypertension - Year-over-year growth 2021-2026 (%)

5.4 Pulmonary hypertension - Market size and forecast 2021-2026
- Exhibit 32: Chart on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.10 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

7.11 Japan - Market size and forecast 2021-2026
- Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption

9.4 Industry risks
- Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 83: Vendors covered

10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification

10.3 AstraZeneca Plc
- Exhibit 85: AstraZeneca Plc - Overview
- Exhibit 86: AstraZeneca Plc - Product / Service
- Exhibit 87: AstraZeneca Plc - Key news
- Exhibit 88: AstraZeneca Plc - Key offerings

10.4 Bayer AG
- Exhibit 89: Bayer AG - Overview
- Exhibit 90: Bayer AG - Business segments
- Exhibit 91: Bayer AG - Key offerings
- Exhibit 92: Bayer AG - Segment focus

10.5 Dr Reddys Laboratories Ltd
- Exhibit 93: Dr Reddys Laboratories Ltd - Overview
- Exhibit 94: Dr Reddys Laboratories Ltd - Business segments
- Exhibit 95: Dr Reddys Laboratories Ltd - Key offerings
- Exhibit 96: Dr Reddys Laboratories Ltd - Segment focus

10.6 GlaxoSmithKline Plc
- Exhibit 97: GlaxoSmithKline Plc - Overview
- Exhibit 98: GlaxoSmithKline Plc - Business segments
- Exhibit 99: GlaxoSmithKline Plc - Key news
- Exhibit 100: GlaxoSmithKline Plc - Key offerings
- Exhibit 101: GlaxoSmithKline Plc - Segment focus

10.7 Johnson and Johnson
- Exhibit 102: Johnson and Johnson - Overview
- Exhibit 103: Johnson and Johnson - Business segments
- Exhibit 104: Johnson and Johnson - Key news
- Exhibit 105: Johnson and Johnson - Key offerings
- Exhibit 106: Johnson and Johnson - Segment focus

10.8 Lupin Ltd
- Exhibit 107: Lupin Ltd - Overview
- Exhibit 108: Lupin Ltd - Product / Service
- Exhibit 109: Lupin Ltd - Key news
- Exhibit 110: Lupin Ltd - Key offerings

10.9 Merck and Co. Inc.
- Exhibit 111: Merck and Co. Inc. - Overview
- Exhibit 112: Merck and Co. Inc. - Business segments
- Exhibit 113: Merck and Co. Inc. - Key news
- Exhibit 114: Merck and Co. Inc. - Key offerings
- Exhibit 115: Merck and Co. Inc. - Segment focus

10.10 Novartis AG
- Exhibit 116: Novartis AG - Overview
- Exhibit 117: Novartis AG - Business segments
- Exhibit 118: Novartis AG - Key offerings
- Exhibit 119: Novartis AG - Segment focus

10.11 Pfizer Inc.
- Exhibit 120: Pfizer Inc. - Overview
- Exhibit 121: Pfizer Inc. - Product / Service
- Exhibit 122: Pfizer Inc. - Key news
- Exhibit 123: Pfizer Inc. - Key offerings

10.12 Sanofi SA
- Exhibit 124: Sanofi SA - Overview
- Exhibit 125: Sanofi SA - Business segments
- Exhibit 126: Sanofi SA - Key news
- Exhibit 127: Sanofi SA - Key offerings
- Exhibit 128: Sanofi SA - Segment focus

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources

11.5 List of abbreviations
- Exhibit 135: List of abbreviations

health: Includes veterinary drugs (excluded from the scope of the report)

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

antihypertensive drugs market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis